Krabatsch Thomas, Schweiger Martin, Stepanenko Alexander, Drews Thorsten, Potapov Evgenij, Vierecke Juliane, Jurmann Beate, Pasic Miralem, Weng Yu-Guo, Huebler Michael, Hetzer Roland
Klinik für Herz- Thorax- und Gefäßchirurgie, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin.
Anasthesiol Intensivmed Notfallmed Schmerzther. 2011 Jun;46(6):414-21; quiz 422. doi: 10.1055/s-0031-1280746. Epub 2011 Jun 17.
Ventricular assist devices (VAD) to support the left (LVAD), the right (RVAD) or both ventricles (BVAD) have emerged as one standard of care for advanced heart failure patients. Initially used to bridge patients to transplantation (BTT) they are now more frequently implanted as permanent support (destination therapy, DT). Bridge to recovery (BTR) is a valid option for only a small number of patients. Although there are different devices available, patient selection, preoperative and intraoperative management, and the timing of VAD implantation are the elements critical to successful circulatory support.
用于支持左心室（左心室辅助装置，LVAD）、右心室（右心室辅助装置，RVAD）或双心室（双心室辅助装置，BVAD）的心室辅助装置已成为晚期心力衰竭患者的一种标准治疗手段。最初用于将患者过渡到移植（桥接至移植，BTT），现在它们更常作为永久性支持手段植入（终末期治疗，DT）。桥接至恢复（BTR）仅对少数患者是一种有效的选择。尽管有不同的装置可供使用，但患者选择、术前和术中管理以及心室辅助装置植入的时机是成功进行循环支持的关键因素。
